"No metabolic abnormality to suggest active lymphoma."
No sweeter words exist right now. Translated...my final PET/CT scan was clear! Hodgkin's Lymphoma has left the building, hopefully never to return.
Read it for yourself:
 |
| Just an Awesome Result! |
While I was expecting nothing less, it was an incredible feeling to see that result in the final report and then hear it from Dr. Seifter.
As I've stated more than once in this blog, I am a fortunate and lucky man. Fortunate to be surrounded by so many loving and supportive family members and friends. Fortunate to have world class medical resources nearby. And lucky to be able to get over this "speed bump" in my life with nothing more than a few minor complications. While my chances of relapse are small and the chances of another cancer due to the chemo regimen are small as well (1-in-200), I am looking forward to being deemed as "cured" a few years from now.
Thank you all...and much love to each and every one of you. And thanks so much to everyone who has supported Alison's triathlon quest. She met her goal in less than 3 days - you all are awesome.
PS...I'll continue to send out periodic updates on the blog. I will see Dr. Seifter on June 21 for my first 3-month check up.
2 comments:
Awesome!!!!!!!!
Hi Michael,
I saw your blog and I’m reaching out to you regarding an Hodgkin's Lymphoma Market Research Panel. I hope this email finds you well.
I’m working with my client on behalf of Xcenda, part of AmerisourceBergen Consulting Services, who are an independent market research firm that works with pharmaceutical and biotech companies. Xcenda is currently looking for individuals who are interested in being on an informational panel for market research projects focused on Hodgkin's Lymphoma (HL). These will not be medical studies but might include asking for your thoughts and opinions on medications, or asking for your suggestions on how to improve reading materials such as educational brochures.
Because Xcenda is an independent market research company, any personal information that you give will be kept confidential from any company other than us (SMRG), and Xcenda. The way this panel works is that we would go through a few questions now to see if you qualify, and if you do – and choose to join the panel – we will pass your information onto Xcenda who will send you $50 for joining, and provide you with direct contact information in case you have any questions. Once you’ve agreed to join, Xcenda will put your contact information into
their database and then contact you whenever they have market research projects available. Participation is always completely voluntary, but you would be compensated each time you take part.
Finally, the Xcenda Hodgkin's Lymphoma(HL) Market Research Panel works on an opt-in basis. Once we have gone through some questions to see if you qualify, it is your choice to enroll in this panel. Equally, if you ever decide you no longer wish to be a member of this panel, you can call or email Xcenda directly, and they will remove your information from their system.
Would this be something you might be interested in? If so, you and I can go through a few more questions over the phone to see if you qualify to join our panel.
Thank you so much for your time and I look forward to hearing from you!
Best,
Anjie
anjalee@smrginc.com
773-697-7612
Post a Comment